Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Marsh

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Pharmacogenomics|May 19, 2012
Identification of novel markers for 5-FU and FOLFOX toxicitySharon Marsh
Methods in Molecular Biology (Clifton, N.J.)|December 23, 2006
Pyrosequencing applicationsSharon Marsh
Molecular Diagnosis & Therapy|April 3, 2007
Impact of pharmacogenomics on clinical practice in oncologySharon Marsh
Personalized Medicine|May 23, 2018
Taxane pharmacogeneticsSharon Marsh
Investigational New Drugs|November 4, 2005
Thymidylate synthase pharmacogeneticsSharon Marsh
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Cancer pharmacogeneticsSharon Marsh
Pharmacogenomics|July 5, 2012
EGFR R521K predicts cetuximab response in KRAS wild-type patientsSharon Marsh
Pharmacogenomics|July 5, 2012
CD133 as a marker of response to bevacizumabSharon Marsh
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2009
Pharmacogenomics of taxane/platinum therapy in ovarian cancerSharon Marsh
Pharmacogenomics|April 4, 2008
Pharmacogenetics: global clinical markersSharon Marsh
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Pharmacogenomics|May 19, 2012
Identification of novel markers for 5-FU and FOLFOX toxicitySharon Marsh
Methods in Molecular Biology (Clifton, N.J.)|December 23, 2006
Pyrosequencing applicationsSharon Marsh
Molecular Diagnosis & Therapy|April 3, 2007
Impact of pharmacogenomics on clinical practice in oncologySharon Marsh
Personalized Medicine|May 23, 2018
Taxane pharmacogeneticsSharon Marsh
Investigational New Drugs|November 4, 2005
Thymidylate synthase pharmacogeneticsSharon Marsh
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Cancer pharmacogeneticsSharon Marsh
Pharmacogenomics|July 5, 2012
EGFR R521K predicts cetuximab response in KRAS wild-type patientsSharon Marsh
Pharmacogenomics|July 5, 2012
CD133 as a marker of response to bevacizumabSharon Marsh
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2009
Pharmacogenomics of taxane/platinum therapy in ovarian cancerSharon Marsh
Pharmacogenomics|April 4, 2008
Pharmacogenetics: global clinical markersSharon Marsh
Pageof 9